The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular Bpc 157 bone healing: 2025's Crucial Warning. Sources: U.S. Food and Drug Administration (FDA) Compounding and the FDA (503A & 503B guidance) FDA warning letters on unapproved peptide products National Institutes of Health (NIH) PubMed FDA Moves to Reevaluate Several Peptides American Med Spa Association FDA takes first step in possible reversal of ban on some peptides The Washington Post BPC 157: Prohibited peptide and unapproved drug in supplements